Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Canada House Wellness Group Inc stock logo
CHV
Canada House Wellness Group
$0.00
$0.00
$0.00
N/AN/AN/A156,525 shs
Diadexus, Inc.  stock logo
DDXS
Diadexus
$0.00
$0.01
$5.40
$53KN/A15,481 shs30 shs
NewMarket Co. stock logo
NEU
NewMarket
$533.06
-8.6%
$615.31
$362.16
$650.00
$5.11B0.4543,794 shs97,257 shs
PREV
PreveCeutical Medical
$0.00
$0.00
$0.00
N/AN/AN/A694,224 shs
TNGN
Tengion
$0.00
$0.00
$0.00
N/AN/A6,051 shs10,000 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Canada House Wellness Group Inc stock logo
CHV
Canada House Wellness Group
0.00%0.00%0.00%0.00%0.00%
Diadexus, Inc.  stock logo
DDXS
Diadexus
0.00%0.00%0.00%0.00%0.00%
NewMarket Co. stock logo
NEU
NewMarket
-0.82%-0.37%-7.68%+3.54%+59.30%
PREV
PreveCeutical Medical
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Canada House Wellness Group Inc stock logo
CHV
Canada House Wellness Group
N/AN/AN/AN/AN/AN/AN/AN/A
Diadexus, Inc.  stock logo
DDXS
Diadexus
N/AN/AN/AN/AN/AN/AN/AN/A
NewMarket Co. stock logo
NEU
NewMarket
1.6051 of 5 stars
0.03.01.70.02.83.31.3
PREV
PreveCeutical Medical
N/AN/AN/AN/AN/AN/AN/AN/A
TNGN
Tengion
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Canada House Wellness Group Inc stock logo
CHV
Canada House Wellness Group
N/AN/AN/AN/A
Diadexus, Inc.  stock logo
DDXS
Diadexus
N/AN/AN/AN/A
NewMarket Co. stock logo
NEU
NewMarket
N/AN/AN/AN/A
PREV
PreveCeutical Medical
N/AN/AN/AN/A
TNGN
Tengion
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Canada House Wellness Group Inc stock logo
CHV
Canada House Wellness Group
N/AN/AN/AN/AN/AN/A
Diadexus, Inc.  stock logo
DDXS
Diadexus
N/AN/AN/AN/AN/AN/A
NewMarket Co. stock logo
NEU
NewMarket
$2.70B1.89$44.24 per share12.05$112.31 per share4.75
PREV
PreveCeutical Medical
N/AN/AN/AN/AN/AN/A
TNGN
Tengion
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Canada House Wellness Group Inc stock logo
CHV
Canada House Wellness Group
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Diadexus, Inc.  stock logo
DDXS
Diadexus
N/AN/A0.00N/AN/AN/AN/AN/AN/A
NewMarket Co. stock logo
NEU
NewMarket
$388.86M$40.4313.18N/A14.41%41.33%16.70%7/24/2024 (Estimated)
PREV
PreveCeutical Medical
N/AN/A0.00N/AN/AN/AN/AN/AN/A
TNGN
Tengion
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest NEU, CHV, DDXS, PREV, and TNGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/24/2024Q1 2024
NewMarket Co. stock logo
NEU
NewMarket
N/A$11.23+$11.23$11.23N/A$696.74 million    
1/31/2024Q4 2023
NewMarket Co. stock logo
NEU
NewMarket
N/A$8.38+$8.38$8.38N/A$643.35 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Canada House Wellness Group Inc stock logo
CHV
Canada House Wellness Group
N/AN/AN/AN/AN/A
Diadexus, Inc.  stock logo
DDXS
Diadexus
N/AN/AN/AN/AN/A
NewMarket Co. stock logo
NEU
NewMarket
$10.001.88%+5.21%24.73%2 Years
PREV
PreveCeutical Medical
N/AN/AN/AN/AN/A
TNGN
Tengion
N/AN/AN/AN/AN/A

Latest NEU, CHV, DDXS, PREV, and TNGN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/22/2024
NewMarket Co. stock logo
NEU
NewMarket
Quarterly$2.501.58%3/14/20243/15/20244/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Canada House Wellness Group Inc stock logo
CHV
Canada House Wellness Group
N/AN/AN/A
Diadexus, Inc.  stock logo
DDXS
Diadexus
N/AN/AN/A
NewMarket Co. stock logo
NEU
NewMarket
0.60
2.85
1.60
PREV
PreveCeutical Medical
N/AN/AN/A
TNGN
Tengion
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Canada House Wellness Group Inc stock logo
CHV
Canada House Wellness Group
N/A
Diadexus, Inc.  stock logo
DDXS
Diadexus
N/A
NewMarket Co. stock logo
NEU
NewMarket
61.09%
PREV
PreveCeutical Medical
N/A
TNGN
Tengion
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Canada House Wellness Group Inc stock logo
CHV
Canada House Wellness Group
N/AN/AN/ANot Optionable
Diadexus, Inc.  stock logo
DDXS
Diadexus
N/A4.10 millionN/ANot Optionable
NewMarket Co. stock logo
NEU
NewMarket
2,0009.59 million7.63 millionOptionable
PREV
PreveCeutical Medical
N/AN/AN/ANot Optionable
TNGN
Tengion
147,000N/AN/ANot Optionable

NEU, CHV, DDXS, PREV, and TNGN Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Canada House Wellness Group logo

Canada House Wellness Group

CNSX:CHV
Canada House Cannabis Group Inc., through its subsidiaries, provides medical grade cannabis products in Canada. The company offers cannabinoid therapy products and services to patients, as well as owns and operates medicinal cannabis clinics. It also provides a cloud-based software that links physicians, providers, and patients to data that supports treatment with medical cannabis. The company serves its products under the Abba Medix, ICM Air, ICM Fogo, H-Series, Fleurs de chez nous, and Vandoos brand names. Canada House Cannabis Group Inc. is headquartered in Pickering, Canada.
Diadexus logo

Diadexus

OTCMKTS:DDXS
Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA.
NewMarket logo

NewMarket

NYSE:NEU
NewMarket Corporation, through its subsidiaries, primarily engages in the manufacture and sale of petroleum additives. The company offers lubricant additives for use in various vehicle and industrial applications, including engine oils, transmission fluids, off-road powertrain and hydraulic systems, gear oils, hydraulic oils, turbine oils, and other applications where metal-to-metal moving parts are utilized; engine oil additives designed for passenger cars, motorcycles, on and off-road heavy duty commercial equipment, locomotives, and engines in ocean-going vessels; driveline additives designed for products, such as transmission fluids, axle fluids, and off-road powertrain fluids; and industrial additives designed for products for industrial applications consisting of hydraulic fluids, grease, industrial gear fluids, and industrial specialty applications, such as turbine oils. It also provides fuel additives that are used to enhance the oil refining process and the performance of gasoline, diesel, biofuels, and other fuels to industry, government, original equipment manufacturers, and individual customers. In addition, the company engages in the marketing of antiknock compounds, as well as contracted manufacturing and services activities; and owns and manages a real property in Virginia. It operates in North America, Latin America, Asia Pacific, Europe, the Middle East, Africa, and India. NewMarket Corporation was founded in 1887 and is headquartered in Richmond, Virginia.

PreveCeutical Medical

CNSX:PREV
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.

Tengion

OTCMKTS:TNGN
Tengion, Inc. is a medicine company, focuses on discovering, developing, manufacturing and commercializing of neo-organs and products. The company was founded by Steven Nichtberger and David I. Scheer on July 10, 2003 and is headquartered in Winston-Salem, NC.